Search tips
ECCMID 2023
Courses & Events
Guidelines
From the archive: ECCMID and more before 2010
Search Results
Sort by:
Filter 0
Sort by
Filter
Sort by
Relevance
Date descending
Date ascending
13 March 2024
Optimal dosing and continuous or prolonged infusion of beta-lactams and vancomycin – what is the evidence?
Sonia Luque Pardos
17 April 2023 - P2229
Increase of the activity of a therapeutic drug monitoring service of vancomycin in the last four years during the pandemic in a tertiary university hospital
Agustí Albalat Torres, Sonia Luque, L Sorli, Alba Arderiu Formentí, Ma Papagna Millán, Monica Marín-Casino, Olivia Ferrández Quirante, Santiago Grau
17 April 2023 - P2208
Achievement of the PK/PD target and therapeutic drug monitoring of ceftaroline administered by intermitent, extended and continuous infusion
Daniel Fresan, Sonia Luque, Agustí Albalat, Luisa Sorli, Maria Milagro Montero, Marta De Antonio, Rosana Muñoz, Nuria Prim, Juan Pablo Horcajada, Santiago Grau
17 April 2023 - P2231
Evaluation of apotransferrin in combination with ceftolozane/tazobactam as an innovative therapy in extensively resistant Pseudomonas aeruginosa infections in an in vitro PK/PD model
Maria Milagro Montero, Sandra Domene-Ochoa, Dani Echeverría-Esnal, Carla López-Causapé, Sonia Luque, Luisa Sorli, Inmaculada López-Montesinos, Eduardo Padilla, Núria Prim, Santiago Grau, Antonio Oliver, Juan Pablo Horcajada
17 April 2023 - P2207
Effectiveness, safety and probability of PK/PD target achievement of ceftazidime/avibactam and ceftolozane/tazobactam vs colistin-based regimens in the treatment of hospital-acquired pneumonia caused by extensively-drug resistant Pseudomonas aeruginos
Luisa Sorli, Sonia Luque, Laura Rio, Xenia Fernández, M Eugenia Navarrete, Adela Benítez-Cano, Joan Gómez-Junyent, Silvia Gómez-Zorrilla, Ivan Pelegrín, Judith Poblet, Jesus Alonso-Carrillo, Inmaculada López-Montesinos, Milagro Montero, Santiago Grau, Juan Pablo Horcajada
17 April 2023 - P2254
Staggered vs simultaneous administration of meropenem and amikacin in combined therapy against carbapenemase-carrying Klebsiella pneumoniae: may dosing schedule influence the initial decrease in the bacterial load?
Berta Puig-Collderram, Alba Crespo-Carrasco, Natalia Garcia-Caballero, Natalia Mingorance-Garcia, Amaya Suárez, Sandra Domene-Ochoa, Luisa Sorli, Sonia Luque, Daniel Echevarría-Esnal, Maria Milagro Montero, Concepción Segura, Juan Pablo Horcajada, Santiago Grau, Eduardo Padilla, Núria Prim
15 April 2023 - O0266
Burden of hospitalisations due to prosthetic joint infection in Spain during the period 2000-2015
Joan Gómez-Junyent, Luisa Sorli, Ivan Pelegrín, Lluis Puig, Albert Alier, Daniel Pérez-Prieto, Judith Poblet, Sonia Luque, María Milagro Montero, Juan Pablo Horcajada
15 April 2023 - P0684
Characteristics, microbiology and outcome of osteoarticular infections by multidrug-resistant Gram-negative bacilli
Laura Navarro-Desentre, Joan Gómez-Junyent, Luisa Sorli, Juan José Fernández-Díaz, Núria Prim, Albert Alier, Daniel Pérez-Prieto, Lluis Puig, Ivan Pelegrín, Judith Poblet, Sonia Luque, María Milagro Montero, Juan Pablo Horcajada
26 April 2022 - O0900
Colistin for the treatment of osteoarticular infections caused by extensively drug-resistant Pseudomonas aeruginosa: pharmacokinetics, safety and clinical efficacy
Joan Gómez-Junyent, Luisa Sorli, Sonia Luque, Núria Campillo, Lluís Puig, Albert Alier, Daniel Pérez-Prieto, Núria Prim, María Milagro Montero, Iván Pelegrín, Santiago Grau, Juan Pablo Horcajada
24 April 2022 - O0305
Pharmacokinetics and safety of colistin in older adults with extensively drug-resistant Gram-negative bacterial infections
Luisa Sorli, Sonia Luque, Isabel Arnau, Roberto Güerri, Nuria Campillo, Joan Gomez-Junyent, Ivan Pelegrin, Silvia Gómez-Zorrilla, Inmaculada Lopez, Mar Arenas, Milagro Montero, Santiago Grau, Juan Pablo Horcajada
23 April 2022 - P1347
Achievement of the PK/PD target and therapeutic drug monitoring of ceftazidime/avibactam administered by continuous infusion in patients with infections caused by antibiotic-resistant gram-negative bacteria
Daniel Fresan, Sonia Luque, Luisa Sorli, Adela Benitez-Cano, Nuria Campillo, Nuria Prim, Maria Milagro Montero, Inmaculada Lopez Montesinos, Juan Pablo Horcajada, Santiago Grau
23 April 2022 - P0798
Activity of ceftazidime/avibactam in combination with aztreonam against carbapenemase-producing Pseudomonas aeruginosa
Maria Milagro Montero, Sandra Domene-Ochoa, Carla López-Causapé, Sonia Luque, Luisa Sorli, Inmaculada López-Montesinos, Núria Campillo, Eduardo Padilla, Núria Prim, Santiago Grau, Antonio Oliver, Juan Pablo Horcajada
09 July 2021 - 4459
Comparative plasma pharmacokinetics and pharmacodynamics of different surgical antimicrobial prophylactic regimens in patients undergoing total knee and hip arthroplasty (TKA/THA) against bacteria isolated from patients with TKA/THA prosthetic joint infec
Sonia Luque, S. Luque (1), A. Rivera (2), A. Gállego (3), C.S. Batista (2), N. Campillo (4), E. Navarrete (4), R. Altaba (2), A. Sánchez (2), I. Mur (3), L. Puig (5), X. Crusi (6), J.C. González (6), L. Sorlí (7), J.P. Horcajada (7), F. Navarro (2), N. Benito (3)
16 April 2019 - O1169
Colistin use in patients with chronic kidney disease: are we underdosing patients?
Luisa Sorlí, Sonia Luque, Xènia Fernandez, Nuria Campillo, Jade Soldado, Ignacio Domingo, M Milagro Montero, Santiago Grau Cerrato, Juan Pablo Horcajada
16 April 2019 - O1174
Does expanded Gram-negative antimicrobial prophylaxis reduce the risk for prosthetic joint infection after joint arthroplasty surgery?
Natividad Benito, Luisa Sorli, Isabel Mur, Lluis Puig Verdie, Alba Rivera, Alex Ruiz, Xavier Crusi, Sonia Luque, Jose Carlos Gonzalez, Sergi Rodriguez, Juan P. Horcajada
16 April 2019 - O1067
Population pharmacokinetics and pharmacodynamics of anidulafungin against Candida albicans in a cohort of critically ill patients
Sonia Luque, William Hope, Nuria Campillo, Rosana Muñoz, Luisa Sorlí, Jaime Barceló-Vidal, Francisco Alvarez-Lerma, Joan Ramon Masclans, M Milagro Montero, Juan Pablo Horcajada, Santiago Grau Cerrato
15 April 2019 - P2112
In vitro evaluation of ceftolozane/tazobactam and colistin alone and in combination against extensively drug-resistant Pseudomonas aeruginosa
Maria Milagro Montero, M Milagro Montero, Sandra Domene Ochoa, Carla Lopez Causape, Sonia Luque, Luisa Sorlí, Nuria Campillo, Eduardo Padilla, Nuria Prim, Concha Segura Alvarez, Virginia Pomar, Maria Alba Rivera, Santiago Grau, Antonio Oliver, Juan Pablo Horcajada
24 April 2018 - P2196
Colistin for the treatment of symptomatic urinary tract infections caused by extremely drug resistant Pseudomonas aeruginosa: are the current doses of colistin too high?
Sonia Luque, L. Sorlí, S. Luque, N. Campillo, C. Segura, M. Montero, J. Ruiz Arboleda, S. Rodriguez, S. Grau Cerrato, J. Horcajada
12 April 2016 - P1602
Population pharmacokinetics of micafungin in plasma and burn eschar in severely burned critically-ill patients
Sonia Luque, Luque Sonia, Chamani-Tabriz Leili, A. García de Lorenzo Y Mateos, S. Luque, S. Grau, A. Agrifoglio, L. Cachafeiro, E. Herrero, M. Asensio, M. Sánchez, J. Roberts
09 April 2016 - EV0648
Linezolid use in patients with low body weight: is there really a need to reduce the dose to prevent haematological toxicity?
Sonia Luque, Luque Sonia, S. Luque, A. Retamero, N. Campillo, R. Muñoz, L. Sorli, J. Horcajada, F. Alvarez Lerma, E. Salas, S. Grau
Loading ...
+ load more
FAQ
To access content in the eLibrary you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ECCMID where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.